IDEXX Laboratories Inc. is seeing a notable increase in its stock price, thanks to strong market forecasts and positive growth indicators.
IDEXX Laboratories Inc. (NASDAQ:IDXX) is up today, with shares rising 1.60% to close at CA$527.59. This uptick comes amid promising forecasts for the companion animal diagnostics market, which is expected to grow significantly in the coming years.
Investor takeaway: Investors should consider the strong growth potential in the companion animal diagnostics sector, where IDEXX is well-positioned to succeed, despite some existing challenges.
Advertisement
IDEXX Laboratories Inc
IDXX.US
IDXX.US
IDEXX Laboratories Inc
WealthAwesomeMarket cap
$40.96B
P/E
36.4x
52W high
$769.98
52W low
$500.61
1W change
+1.49%
Beta
1.54
Analyst Price Targets
Based on 13 analysts covering IDXX · as of Sep 28, 2026
Wall Street analysts forecast IDXX stock price to rise 35.1% over the next 12 months.
Consensus
Buy3.62 / 5.00
Avg. Target
C$701.33
+35.1% Upside
Previously C$698.92 on Sep 17, 2026
Current Price
C$519.26
Last close
Analyst Breakdown (13 analysts)
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on IDXX's historical volatility
30-Day Vol
23.8%
Annualized
90-Day Vol
28.6%
Annualized
Trend (90d)
-14.6%
Annualized drift
90d Mean
C$492.94
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$510.34 | C$470.06 – C$554.07 |
| 60 trading days | C$501.56 | C$446.51 – C$563.41 |
| 90 trading days | C$492.94 | C$427.52 – C$568.38 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Bull case
The companion animal diagnostics market is projected to grow from $3.56 billion in 2026 to $5.40 billion by 2031. This growth is driven by increasing spending on pet healthcare and advancements in diagnostic technology. IDEXX's strong recurring revenue growth and expanding diagnostic offerings enhance its position in this market.
Bear case
Even with its growth potential, IDEXX faces challenges like foreign exchange fluctuations and a decline in U.S. veterinary clinical visits, which could limit its overall growth trajectory.
Advertisement
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
